[English] 日本語
Yorodumi- PDB-4epy: Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-m... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 4epy | ||||||
|---|---|---|---|---|---|---|---|
| Title | Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation | ||||||
Components | GTPase KRas | ||||||
Keywords | HYDROLASE / Small molecule complex crystal structure / KRas / p21 / GTP-binding protein / oncogenes / binder / Inhibitor of Sos-mediated activation | ||||||
| Function / homology | Function and homology informationresponse to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation ...response to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation / Rac protein signal transduction / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / myoblast proliferation / skeletal muscle cell differentiation / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / positive regulation of glial cell proliferation / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / cardiac muscle cell proliferation / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Estrogen-stimulated signaling through PRKCZ / glial cell proliferation / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / p38MAPK events / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / striated muscle cell differentiation / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / homeostasis of number of cells within a tissue / CD209 (DC-SIGN) signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / Insulin receptor signalling cascade / SHC1 events in ERBB2 signaling / Ras activation upon Ca2+ influx through NMDA receptor / response to glucocorticoid / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / small monomeric GTPase / FCERI mediated MAPK activation / liver development / Signaling by ERBB2 TMD/JMD mutants / female pregnancy / RAF activation / Signaling by SCF-KIT / Signaling by high-kinase activity BRAF mutants / Constitutive Signaling by EGFRvIII / regulation of long-term neuronal synaptic plasticity / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / visual learning / cytoplasmic side of plasma membrane / cytokine-mediated signaling pathway / Regulation of RAS by GAPs / Signaling by CSF1 (M-CSF) in myeloid cells / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / Signaling by BRAF and RAF1 fusions / positive regulation of cellular senescence / DAP12 signaling / MAPK cascade / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / MOLECULAR REPLACEMENT / Resolution: 1.801 Å | ||||||
Authors | Sun, Q. / Burke, J.P. / Phan, J. / Burns, M.C. / Olejniczak, E.T. / Waterson, A.G. / Lee, T. / Rossanese, O.W. / Fesik, S.W. | ||||||
Citation | Journal: Angew.Chem.Int.Ed.Engl. / Year: 2012Title: Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation. Authors: Sun, Q. / Burke, J.P. / Phan, J. / Burns, M.C. / Olejniczak, E.T. / Waterson, A.G. / Lee, T. / Rossanese, O.W. / Fesik, S.W. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 4epy.cif.gz | 57.9 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb4epy.ent.gz | 39.3 KB | Display | PDB format |
| PDBx/mmJSON format | 4epy.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 4epy_validation.pdf.gz | 984.7 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 4epy_full_validation.pdf.gz | 986.5 KB | Display | |
| Data in XML | 4epy_validation.xml.gz | 11.9 KB | Display | |
| Data in CIF | 4epy_validation.cif.gz | 17.7 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/ep/4epy ftp://data.pdbj.org/pub/pdb/validation_reports/ep/4epy | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 4eprC ![]() 4eptC ![]() 4epvSC ![]() 4epwC ![]() 4epxC C: citing same article ( S: Starting model for refinement |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 19354.824 Da / Num. of mol.: 1 / Mutation: G12V, C118S Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: ![]() |
|---|---|
| #2: Chemical | ChemComp-GDP / |
| #3: Chemical | ChemComp-MG / |
| #4: Chemical | ChemComp-0QY / |
| #5: Water | ChemComp-HOH / |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 1.91 Å3/Da / Density % sol: 35.75 % |
|---|---|
| Crystal grow | Temperature: 291 K / Method: vapor diffusion, sitting drop / pH: 4 Details: 28% PEG4000, 0.1 M MMT, 0.2 M ammonium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 291K |
-Data collection
| Diffraction | Mean temperature: 100 K |
|---|---|
| Diffraction source | Source: ROTATING ANODE / Type: BRUKER AXS MICROSTAR / Wavelength: 1.5418 Å |
| Detector | Type: Bruker Platinum 135 / Detector: CCD / Date: Nov 5, 2011 |
| Radiation | Monochromator: Montel confocal, multi-layer mirrors / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.5418 Å / Relative weight: 1 |
| Reflection | Resolution: 1.8→27.13 Å / Num. all: 14390 / Num. obs: 13808 / % possible obs: 96 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 / Rmerge(I) obs: 0.087 / Net I/σ(I): 13.8 |
| Reflection shell | Resolution: 1.8→1.83 Å / Redundancy: 1.3 % / Rmerge(I) obs: 0.098 / Mean I/σ(I) obs: 7 / % possible all: 39.8 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 4EPV Resolution: 1.801→27.13 Å / SU ML: 0.38 / σ(F): 1.34 / Phase error: 17.13 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.86 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL / Bsol: 29.295 Å2 / ksol: 0.327 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters |
| ||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.801→27.13 Å
| ||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Citation














PDBj























